David Turkaly
Stock Analyst at JMP Securities
(2.33)
# 2,347
Out of 4,829 analysts
137
Total ratings
40.48%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $13.67 | +82.88% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $36.57 | +50.40% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $98.22 | +27.27% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $429.44 | +16.43% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $388.08 | - | 3 | May 5, 2025 | |
| STE STERIS | Reiterates: Market Outperform | $265 | $233.10 | +13.69% | 17 | Apr 10, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $129.24 | - | 15 | Apr 2, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $12 → $7 | $1.01 | +593.07% | 6 | Mar 21, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $23.27 | +114.87% | 10 | Mar 21, 2025 | |
| AXGN Axogen | Reiterates: Market Outperform | $26 | $11.39 | +128.27% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $18.77 | +70.53% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $59.01 | - | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $125 → $100 | $70.26 | +42.33% | 11 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $9.21 | +73.72% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $79.52 | +40.85% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.11 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $4.14 | -27.54% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $12.43 | - | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.71 | +7.82% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.96 | -49.80% | 1 | Oct 6, 2017 |
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $13.67
Upside: +82.88%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $36.57
Upside: +50.40%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $98.22
Upside: +27.27%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $429.44
Upside: +16.43%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $388.08
Upside: -
STERIS
Apr 10, 2025
Reiterates: Market Outperform
Price Target: $265
Current: $233.10
Upside: +13.69%
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $129.24
Upside: -
TELA Bio
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.01
Upside: +593.07%
OrthoPediatrics
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $23.27
Upside: +114.87%
Axogen
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $11.39
Upside: +128.27%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $18.77
Upside: +70.53%
Feb 24, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $59.01
Upside: -
Feb 7, 2025
Maintains: Market Outperform
Price Target: $125 → $100
Current: $70.26
Upside: +42.33%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $9.21
Upside: +73.72%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $79.52
Upside: +40.85%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.11
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $4.14
Upside: -27.54%
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.43
Upside: -
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.71
Upside: +7.82%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.96
Upside: -49.80%